NAGE

Niagen Bioscience Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 9/10
  • Value↓ 4/10
Niagen Bioscience sales and earnings growth
NAGE Growth
Great
  • Revenue Y/Y↑ 29.95%
  • EPS Y/Y↑ 100.00%
  • FCF Y/Y↑ 10.41%
Niagen Bioscience gross and profit margin trends
NAGE Profitability
Great
  • Gross margin ↑ 64.30%
  • EPS margin↑ 13.40%
  • ROIC 5Y↑ 48.04%
Niagen Bioscience net debt vs free cash flow
NAGE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Niagen Bioscience stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗